[Clinical experience with L-DOPA in the treatment of parkinsonism].
D000284:Administration, Oral; D000328:Adult; D000367:Age Factors; D000368:Aged; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010300:Parkinson Disease / Q000188:drug therapy* / Q000601:surgery; D012737:Sex Factors; D013788:Thalamus / Q000601:surgery
D004295:Dihydroxyphenylalanine